<DOC>
	<DOCNO>NCT01368536</DOCNO>
	<brief_summary>This study ass safety efficacy Valturna amlodipine Valturna chlorthalidone compare Valturna alone patient stage 2 hypertension diabetes mellitus 2 .</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Combination Valturna Amlodipine Valturna Chlorthalidone Versus Valturna Alone Patients With Stage 2 Hypertension Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients stage 2 hypertension within protocol limit randomization Patients type 2 diabetes mellitus HgA1c le equal 9 % Patients newly diagnose hypertension patient receive antihypertensive therapy least 4 week prior screen Patients take 4 antihypertensive medication screen visit Patients uncontrolled BP ( &gt; 140/90 mmHg ) take 3 antihypertensive maximum approved dos Type 2 diabetes mellitus require insulin treatment Patients HgA1c &gt; 9 % Patients know gout Known history cancer within past 5 year Patients pregnant nursing mother Patients participate investigational clinical trial within 30 day prior screen . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>High blood pressure</keyword>
	<keyword>diabetes</keyword>
</DOC>